Head-to-head dispatch
EdgeRx vs Enhance MD
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
A men's-only protocol shop with flat, disclosed GLP-1 pricing, a named Chief Medical Advisor, and a named 503A compounding pharmacy — rare transparency for this tier of the ranking.
Marked down on: Men-only — not built for or marketed to women or other readers
Desk Score
The clearest tiered compounded pricing in the ranking — separate lines for sema, tirzepatide, a microdose tier, and a sema+tirz combo — with lab testing built in.
Marked down on: Compounded only — not FDA-approved
Enhance MD takes this head-to-head with the higher Desk Score, 85/100 (B) against 82/100 (B−) for EdgeRx. EdgeRx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
EdgeRx
82/100
B−
Enhance MD
85/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | EdgeRx | Enhance MD |
|---|---|---|
| Semaglutide | $229/mo injectable | $249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay |
| Tirzepatide | $299/mo injectable | $329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay |
| Coverage | 46 states (excludes Arkansas, Indiana, Minnesota, South Carolina) | Not publicly listed |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Men who want a straightforward, disclosed weekly-injectable price on either molecule and value knowing the pharmacy by name. | Patients who want fully itemized compounded options and ongoing metabolic oversight, and don't need brand-name or oral routes. |
| Desk Score | 82/100B− | 85/100B |
The verdict
Desk pick — Enhance MDEnhance MD takes this head-to-head with the higher Desk Score, 85/100 (B) against 82/100 (B−) for EdgeRx. EdgeRx still holds its ground where its strengths line up with yours.
Choose EdgeRx if…
Men who want a straightforward, disclosed weekly-injectable price on either molecule and value knowing the pharmacy by name.
$229/mo injectable sema · $299/mo injectable tirz · 46 states (excludes Arkansas, Indiana, Minnesota, South Carolina)
Choose Enhance MD if…
Patients who want fully itemized compounded options and ongoing metabolic oversight, and don't need brand-name or oral routes.
$249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay sema · $329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay tirz · Not publicly listed
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: EdgeRx · Enhance MD.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- EdgeRx vs CoreAge Rx
- Enhance MD vs Vaylen
- EdgeRx vs Strut Health
- Enhance MD vs Ondra Health
- EdgeRx vs Invigor Medical
- Enhance MD vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.